Research News and Research

RSS

Women view their weight wrong: Study

Researchers have found that among more than 2,200 women ages 18 to 25 seen at several Texas reproductive-health clinics there were many who did not know if they weighed normal or were overweight.

23 Nov 2010

Exercise combo best for type 2 diabetes: Study

A new study shows that a combination of aerobic exercise and resistance training may offer the biggest benefits for people with type 2 diabetes in helping them control their disease. This combination improved HbA1c levels much better than either form alone. HbA1c levels denote long term sugar or glycemic control in a diabetic patient. Normal HbA1c is 6% or less. People with diabetes are urged to keep their HbA1c below 7%.

23 Nov 2010

Early diagnosis and treatment result in positive outcomes for RA patients

Positive outcomes in rheumatoid arthritis (RA) are closely linked to early diagnosis and treatment with disease-modifying antirheumatic drugs (DMARDs). A study by researchers in the Netherlands found that patients who are assessed by rheumatologists soon after RA symptoms appear are more likely to experience less joint destruction and improved chances of DMARD-free disease remission.

23 Nov 2010

Parkinson Society Canada awards Quebec scientists $573,384 for research

Quebec Parkinson researchers receive a record $573,384 in funding from Parkinson Society Canada to increase their efforts to identify the causes of this degenerative brain disease for which there is currently no cure. At a Research Innovation event in Montreal this evening, hosted by Parkinson Society Quebec in partnership with McGill University and the CHUM, 11 Parkinson scientists will be lauded for their efforts in getting closer to a cure.

23 Nov 2010

ShangPharma third quarter net revenue increases 16.6% to $23.1 million

ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced its financial results for its third quarter ended September 30, 2010.

23 Nov 2010

Innovative new roles and occupations in health sector of the future

Innovative new roles and occupations that could possibly emerge in the health sector of the future are explored in a new working paper published today by Skills for Health.

23 Nov 2010

Ergothioneine international congress 2011 to be held at UCLA

OXIS International, Inc., today announced that the "First International Congress on Ergothioneine, Anti-Oxidants, and Age Management Medicine" will be held Friday to Sunday, July 15-17, 2011, in the DeNeve Auditorium at the University of California, Los Angeles.

23 Nov 2010

Children cannot accurately judge speed of vehicles travelling faster than 20 mph, reveals study

To coincide with Road Safety Week (22-28 November) new research is published today (23 November) revealing primary school children cannot accurately judge the speed of vehicles travelling faster than 20mph.

23 Nov 2010

NC family hopes to win Pepsi Refresh Project grant to fund research for Alternating Hemiplegia of Childhood

A Rolesville, NC family is hoping to win the Pepsi Refresh Project that could help to find a cure for a rare neurological disorder for which there is no current cure. Matthew Wuchich, age 3, was diagnosed with Alternating Hemiplegia of Childhood or AHC when he was 18 months old. Winning the grant is important to the family and to others with the disease since rare diseases often are overlooked by more common ailments.

23 Nov 2010

Scientists establish new biological links between early puberty and obesity

An international group of scientists, including researchers at the Medical Research Council (MRC), has discovered 30 genes that control the age at which girls reach sexual maturity. They found that many of the genes responsible for puberty also play a strong role in how the body metabolises fat, establishing new biological links between going through puberty at a young age and being at increased risk of obesity.

23 Nov 2010

Loyola University professor suggests general travel tips for children with nut allergies

No matter the mode of transportation, holiday travel holds special challenged for parents. Either you're stuck in an enormous security line at an airport filled with cranky people or hearing the constant stream of "are we there yet" from the back seat of the car. It's enough to make a Scrooge out of even the most Tiny Tim of us. For many families adding to the chaos is the reality that their child has a dangerous nut allergy.

23 Nov 2010

Racial disparities in risk and survival among children with neuroblastoma: Study

Black, Asian, and Native American children are more likely than white and Hispanic children to die after being treated for neuroblastoma, according to new research on the pediatric cancer. The study, of more than 3,500 patients with the disease, is the largest ever to look at racial disparities in risk and survival for the most common solid cancer found in young children.

23 Nov 2010

Implanted devices to treat cardiac dysfunction show success in real world use

Implanted devices that treat cardiac dysfunction in heart failure patients are as successful in "real world" use as they are in controlled clinical trial settings, according to a large new study reported in Circulation: Journal of the American Heart Association.

23 Nov 2010

Ziconotide could promote suicidal tendencies: Study

The active agent ziconotide, the synthetic toxin of the cone snail (Conus magus), was acclaimed a safe alternative to morphine when it was introduced six years ago. Now it is increasingly suspected of causing patients to commit suicide. Researchers working under the auspices of Prof. Christoph Maier (Director of the Pain Clinic Bergmannsheil at the Ruhr University in Bochum) presume that ziconotide not only suppresses the transmission of pain stimuli, but also deteriorates the frame of mind and could simultaneously reduce anxiety and impulse control.

23 Nov 2010

Photoacoustic tomography and gold nanobeacons help researchers view blood vessel formation

See it for yourself: a new breakthrough in imaging technology using a combination of light and sound will allow health care providers to see microscopic details inside the body. Access to this level of detail potentially eliminates the need for some invasive biopsies, but it also has the potential to help health care providers make diagnoses earlier than ever before-even before symptoms arise. Details describing this advance are published online in the FASEB Journal (http://www.fasebj.org/content/early/2010/11/19/fj.10-171728.abstract).

23 Nov 2010

Erbitux development program featured in ASCO's Clinical Cancer Advances report for third consecutive year

For the third year in a row, the American Society of Clinical Oncology (ASCO) has included Erbitux® (cetuximab) research in its annual report, Clinical Cancer Advances, which features the most significant studies of 2010. The report cites as a notable advance this year the finding that BRAF mutation status is a prognostic, not predictive, marker for Erbitux efficacy in metastatic colorectal cancer (mCRC).

23 Nov 2010

2010 issue of Johns Hopkins Nursing explores new collaborative opportunities

When it comes to healthcare, an innovative team approach is essential to providing excellent patient care, advancing research, and educating future healthcare providers. The fall/winter 2010 issue of Johns Hopkins Nursing explores how today's nurses work to bridge disciplines and discover new collaborative opportunities.

23 Nov 2010

Study finds biological basis of brain's ability for rapid adaptation

A new study in the Nov. 21 advance online edition of the journal Nature Neuroscience details the biological basis of this ability for rapid adaptation: neurons located at the beginning of the brain's sensory information pathway that change their level of simultaneous firing.

23 Nov 2010

USPTO, EPO issue key patents for Tekmira's LNP technology

Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference therapeutics, announced today that the United States Patent & Trademark Office (USPTO) and the European Patent Office (EPO) have issued key patents covering elements of Tekmira's leading lipid nanoparticle (LNP) technology, which is used to deliver nucleic acid therapeutics, including small interfering RNA (siRNA).

23 Nov 2010

Researchers highlight importance of motivating people to seek HIV testing

HIV infected patients whose treatment is delayed not only become sicker than those treated earlier, but also require tens of thousands of dollars more in care over the first several years of their treatment.

23 Nov 2010